Skip Navigation LinksHome > April 2013 - Volume 118 - Issue 4 > Postoperative Respiratory Muscle Dysfunction: Pathophysiolog...
Anesthesiology:
doi: 10.1097/ALN.0b013e318288834f
Education: Review Article

Postoperative Respiratory Muscle Dysfunction: Pathophysiology and Preventive Strategies

Sasaki, Nobuo M.D.*; Meyer, Matthew J. M.D.; Eikermann, Matthias M.D., Ph.D.

Free Access
Meeting Article
Article Outline
Collapse Box

Author Information

Collapse Box

Abstract

Postoperative pulmonary complications are responsible for significant increases in hospital cost as well as patient morbidity and mortality; respiratory muscle dysfunction represents a contributing factor. Upper airway dilator muscles functionally resist the upper airway collapsing forces created by the respiratory pump muscles. Standard perioperative medications (anesthetics, sedatives, opioids, and neuromuscular blocking agents), interventions (patient positioning, mechanical ventilation, and surgical trauma), and diseases (lung hyperinflation, obesity, and obstructive sleep apnea) have differential effects on the respiratory muscle subgroups. These effects on the upper airway dilators and respiratory pump muscles impair their coordination and function and can result in respiratory failure. Perioperative management strategies can help decrease the incidence of postoperative respiratory muscle dysfunction. Such strategies include minimally invasive procedures rather than open surgery, early and optimal mobilizing of respiratory muscles while on mechanical ventilation, judicious use of respiratory depressant anesthetics and neuromuscular blocking agents, and noninvasive ventilation when possible.
POSTOPERATIVE pulmonary complications (PPC), defined as new onset or exacerbation of respiratory failure following surgery, occur frequently1–3 and are associated with increased rates of short- and long-term mortality,4 as well as increased cost.5 A thorough understanding of the clinical effects of PPC is hindered by inconsistency in the definition of PPC among researchers. The diagnoses classically considered PPC include atelectasis, bronchospasm, pneumonia, pulmonary edema, and respiratory failure.6 Respiratory failure itself is not clearly defined, although the most common criterion is failure to be extubated within 48 h of surgery.6 Adding complexity to assessing the impact of PPC are recent studies which support expanding the definition to include acute upper airway obstruction,7–9 complications from obstructive sleep apnea (OSA),10 chemical pneumonitis,11 and hypoxemia due to abdominal compartment syndrome.12,13
Estimating the incidence of PPC and respiratory failure is complicated for many reasons including the imprecise definitions; however, recent studies attempted exactly this by defining respiratory failure as unplanned reintubation and postoperative mechanical ventilation.3,14
For this small subset of the post-surgical population, the probability of PPC affecting their longevity is great. In 2005, National Surgical Quality Improvement Program data were queried and for patients who were unable to wean from mechanical ventilation after major surgery, the 30-day mortality was 29% (12 times greater than those not experiencing PPC).4 In another cohort study, postoperative reintubation was associated with a 90-fold increase in mortality.14
Along with the huge mortality burden of PPC, there is a significant financial consideration. A 2004 study analyzing hospital cost at the University of Michigan identified PPC as the most expensive of the major postoperative complications. Moreover, when compared to the median hospital cost of $5,015 for surgical patients without PPC, the $62,704 hospital expense for a surgical patient with a pulmonary complication was 12 times greater.5
One underappreciated factor in the development of PPC and respiratory failure is respiratory muscle dysfunction. Upper airway muscles play a vital role in maintaining the anatomic structure of the pharynx and laryngotracheal complex and ensure upper airway patency. Respiratory pump muscles create negative, and occasionally positive, pressure to ventilate and oxygenate. Research shows that even partial respiratory muscle paralysis may lead to more PPC.8,15 In the upper airway, partial paralysis can lead to obstruction16 and increased aspiration risk,17 whereas respiratory pump muscle failure leads to weak cough18 and increased incidence of pneumonia.19 Finally, a 2-week long, preoperative inspiratory muscle training program reduced the incidence of PPC, further demonstrating the importance of respiratory muscle fitness in the prevention of PPC20 and subsequent respiratory failure.
The aim of this article was two-fold: (1) to review the current concepts of postoperative pathophysiology as it pertains to respiratory muscle dysfunction, and (2) to discuss strategies to avoid respiratory muscle dysfunction during the perioperative period and critical illness.
Back to Top | Article Outline

Anatomy and Physiology

The muscles involved in respiration are morphologically and functionally skeletal muscles and can be classified by their anatomic function into two groups: (1) upper airway dilators and (2) respiratory pump muscles. Upper airway dilator muscles counterbalance the negative inspiratory pressure generated by the pump muscle to permit airflow during inspiration. Respiratory pump muscles are the collection of muscles responsible for generating inspiratory and expiratory forces in the thorax.
Back to Top | Article Outline
Upper Airway Patency
Fig. 1
Fig. 1
Image Tools
Patency of the upper airway is maintained by balancing collapsing and dilating forces (fig. 1). The primary upper airway collapsing forces are (1) negative intraluminal pressure generated by the respiratory pump during inspiration and (2) compressive extra-luminal forces from the surrounding tissues. These collapsing forces are opposed by the actions of the upper airway dilator muscles to maintain the airway.
Back to Top | Article Outline
Upper Airway Dilator Muscles.
The actions of the upper airway dilator muscles keep the airway patent. There are many muscles involved in dilating the upper airway; however, the most extensively studied muscles of the upper airway dilators are the genioglossus and the tensor palatine, and experimentally these serve as surrogates for the others. Neurologically, the genioglossus receives a variety of inputs, including phasic (inspiratory) and tonic (non-inspiratory) drive which are distributed differentially across the hypoglossal motoneuron pool.21 In response to negative pharyngeal pressure created by the respiratory pump during inspiration, the genioglossus reflexively stabilizes the upper airway in both humans22 and rats.23 This reflex is likely a product of signaling from inspiratory modulated motor units. Whereas the genioglossus responds to phasic input on top of its tonic (non-respiratory) activation, the tensor palatine is considered a tonic muscle with consistent tone throughout the respiratory cycle.24
Back to Top | Article Outline
Extra-luminal Pressure.
The soft tissues of the pharynx are enclosed and stabilized by bony structures such as the mandible and the spine, and complete collapse of the pharyngeal airway ordinarily requires extra-luminal forces such as hematoma, edema, or peri-pharyngeal masses. Pharyngeal manifestation of obesity compresses the airway.25 Craniofacial abnormalities can further increase the collapsing effects of excessive pharyngeal extra-luminal soft tissue in obese patients and lead to increased pharyngeal collapsibility and OSA26: a disorder involving intermittent nocturnal upper airway collapse. Thus, the extra-luminal soft tissue, and size and shape of the bony enclosure are determinants of the extra-luminal pressure that needs to be antagonized by the upper airway dilator muscle contraction during inspiration in order to avoid an upper airway obstruction-related apnea.26
Back to Top | Article Outline
Body Position.
The effects of body position on upper airway patency have been extensively studied by Isono et al.27,28 The upper airway is more vulnerable to collapse in the supine position than the lateral and sitting positions. Evidence for the lateral position is considerable and frequently based upon research involving subjects with OSA. In sleeping subjects with OSA, fewer obstructive events were reported in the lateral position than supine.29 In anesthetized and paralyzed subjects with OSA, the patency of the passive pharynx was better maintained in the lateral and sitting positions than in the supine.27,28 These improvements in airway patency caused by the lateral position are explained by a less obstructive orientation of the pharyngeal soft tissues.
Back to Top | Article Outline
Respiratory Timing.
The length of the respiratory cycle (Ttot) and variation in its component parts of inspiration (TI) and expiration can affect upper airway patency. Inspiratory duty cycle, also referred to as effective inspiratory time, is the ratio of inspiration to the total respiratory cycle (TI/Ttot), and this can be directly associated with airflow. In fact, increased inspiratory duty cycle can actually compensate for partial airway obstruction.30
Back to Top | Article Outline
Effects of End-expiratory Lung Volume.
A less intuitive component of upper airway patency is lung volume. Higher end-expiratory lung volumes are associated with a decrease in upper airway resistance to airflow in awake healthy humans,31 and an increase in upper airway lumen dimensions in subjects with and without OSA.32 The mechanism for the interaction between upper airway patency and lung volume is thought to lie in the generation of longitudinal traction forces in the trachea.33,34 Upon inspiration, the lung inflates and effectively forces the carina into a more caudal position, thus creating stretching forces on the fixed trachea.34 These forces are transferred to the upper airway walls through assorted soft tissue connections, resulting in improved upper airway dilatation.33 Effectively, tracheal traction allows the respiratory pump muscles to contribute to upper airway patency.
Back to Top | Article Outline
Effects of Fluid Homeostasis on Upper Airway Patency.
Fluid overload can affect upper airway patency. In awake, healthy volunteers, the inflation of antishock trousers displaced so much fluid from the lower extremities that neck circumference increased, the pharynx narrowed,35 and the upper airway had a lower threshold for collapse.36 This concept is reinforced in studies of subjects with lower extremity venous insufficiency37 and congestive heart failure.38 These studies have shown that nocturnal redistribution of fluid from the lower extremities into the neck increases upper airway collapsibility37 and the severity of central and OSAs.38 Future studies in perioperative medicine will show if perioperative fluid restriction helps decrease the vulnerability of the upper airway to collapse.
Back to Top | Article Outline
Respiratory Pump Muscle Activation
The respiratory pump generates the motorized action driving inspiration and expiration. It is the force that broadens the thoracic cavity and creates negative intrathoracic pressure to draw a breath in, and, when needed, positive intrathoracic pressure to exhale rapidly.
Back to Top | Article Outline
Inspiratory Pump Muscles.
Inspiratory pump muscles are an anatomically diverse group, with the best studied being the diaphragm and those of the thoracic wall. The most important inspiratory muscle in healthy humans is the diaphragm, which accounts for 60–70% of lung volume change during simple respiration.39 It is a thin, flat, musculotendinous structure subdivided into the crural diaphragm (originating at the lumbar vertebrae) and the costal diaphragm (originating at the inner surfaces of the lower six ribs); these two divisions function as one during respiration. During inspiration, the volume of the thoracic cavity increases as a result of contraction of the diaphragm and the external intercostal muscles. The lungs expand secondarily to the increased negative intrathoracic pressure generated by these phasic actions of the inspiratory pump muscles.
Inspiratory tone is present in muscles acting on the rib cage and helps to maintain negative intrathoracic pressure.40 There is also inspiratory tone in the diaphragm and its likely purpose is to prevent abdominal viscera mechanically from compressing the lungs.41 The combination of an effective inspiratory tonicity of both the diaphragm and rib cage muscles acting upon the rib cage effectively increases functional residual capacity (FRC) by about 0.8 l.42
Back to Top | Article Outline
Body Position.
Body posture has significant influence on the contribution of respiratory pump muscles to inspiration and lung function. When the torso is upright, the diaphragm is lower in the chest, and the chest circumference changes little compared to that in supine;43 consequently, FRC is about 20% greater upright than supine in humans.44 In the upright position, displacement of the rib cage accounts for approximately 60% of resting tidal volume and in this setting, thoracic wall muscles contribute greatly. In the supine position, rib cage displacement accounts for less than half of the upright tidal volume, and abdominal and diaphragmatic movement contributes significantly more.45 Thus, supine position following surgery renders a patient particularly vulnerable to diaphragmatic dysfunction induced by perioperative medical interventions.
Back to Top | Article Outline
Expiratory Pump Muscles.
The expiratory pump muscles include the internal intercostal, rectus abdominis, external oblique, internal oblique, and transverse abdominis muscles. Expiration at rest is usually passive, relying on the elasticity of the lungs and thorax to return to their equilibrium position. During high breathing effort (i.e., exercise, sepsis, and dysfunctional pulmonary status), the expiratory muscles contract to increase the speed of exhalation, increasing inspiratory duty cycle, in preparation for the next inhalation. Expiratory pump muscles are used in everyday life for speaking, coughing, and airway secretion clearance.
Back to Top | Article Outline

Perioperative Pathophysiology, Treatments, and Interventions Contributing to Respiratory Muscle Dysfunction

Fig. 2
Fig. 2
Image Tools
Perioperative patients are a subset of the general population where respiratory muscle dysfunction occurs frequently and is often due to predictable causes (fig. 2).
Back to Top | Article Outline
Surgery and Trauma
Surgery can be characterized as intentional penetrating trauma that can cause respiratory failure. Procedures on the foregut, the hepatopancreatobiliary region, and the aorta have the strongest association with respiratory failure46; length of surgery is also associated with greater incidence of PPC.47,48 Surgery impairs respiratory pump muscles through a variety of different avenues, leading to increased atelectasis and decreased FRC and decreased vital capacity.49,50 Moreover, the effects are not merely transient but can last from a day to a week,51,52 to upward of a year with phrenic nerve damage.53
There are many mechanisms through which surgery can induce respiratory failure. Some of these reasons are straightforward: functional disruption (cutting, tearing, and retracting) of respiratory muscles (intercostals or rectus abdominis),54–56 postoperative pain leading to voluntary restrictions on respirations,57,58 and phrenic nerve injury resulting in direct diaphragmatic dysfunction.53 Following abdominal or thoracic surgery, patients typically experience a restrictive pattern respiratory abnormality due to impaired respiratory pump muscle function within the first postoperative day. When affected by this restrictive pathology, a patient breathes at reduced lung volumes and FRC diminishes. When FRC decreases below the lung volume where small airway closure generally occurs, entitled closing capacity, regions with low ventilation/perfusion ratios develop, leading to impaired gas exchange and possibly gas trapping and atelectasis.59
Other mechanisms underlying respiratory failure are physiologically more complex. It is well documented that diaphragmatic dysfunction occurs postoperatively,51,60 but the exact mechanism is less certain. In rats, localized, postoperative inflammation has been shown to weaken diaphragm action within hours after exposure.61 Another likely contributor to diaphragmatic dysfunction is the neural inhibitory response to surgical stimulation. In canines, surgical manipulation of the gallbladder has been associated with quick and profound reduction in function of the diaphragm; the rapid time-course of the effect suggests reflex inhibition via vagal afferents.62
In addition, surgery-associated conditions such as peritonitis, systemic inflammatory response syndrome, abdominal trauma, exploratory laparotomies, and fluid shifts following large resuscitations can cause respiratory failure by increasing the intraabdominal pressure, which leads to intraabdominal hypertension (intraabdominal pressure > 12 mmHg) and, in its extreme, abdominal compartment syndrome (intraabdominal pressure > 20 mmHg).63 The external application of abdominal binders may also contribute to increased intraabdominal pressure.64 The increase in intraabdominal pressure can decrease chest wall compliance and diaphragmatic excursion65 which combine to affect respiratory mechanics and increase overall work of breathing for respiratory pump muscles.
Another contributor to respiratory failure is direct chest trauma and rib fractures. One of 13 patients with rib fractures from blunt trauma will have a flail chest, a condition with a 10–20% mortality rate.66 With a flail chest, the negative intrathoracic pressure of inspiration generated by the contraction of the diaphragm and other respiratory muscles draws the flail segment inward, the opposite direction needed to inspire gas, resulting in increased work of breathing and an increase in oxygen consumption.67
Back to Top | Article Outline
Respiratory Arousal
Respiratory muscle function is under both voluntary and involuntary control. Respiratory arousal, as defined by Berry et al.,68 is arousal from sleep due to cumulative and progressive increases in stimuli related to breathing (hypoxia, hypercapnia, and respiratory effort). For our review focused on perioperative medicine, we broaden the definition of the term “respiratory arousal” to include awakening from sleep and other drug-induced or endogenous impairments of consciousness, as well as any neurally mediated restoration of sufficient upper airway and respiratory pump muscle tone independent of patient state of wakefulness.
Fig. 3
Fig. 3
Image Tools
Three primary inputs contribute to respiratory arousal: (1) peripheral and central chemoreceptors sensitive to partial pressures of oxygen and carbon dioxide,69 (2) sensors in the upper airway responsive to negative pressure generated by the respiratory pump,22,23 and (3) cortical stimulation directly related to state of consciousness or “wakefulness.”70 For a visual representation of respiratory arousal, see figure 3.
Any of the three respiratory arousal inputs can restore respiratory muscle tone if the magnitude is great enough. Cortical awakening from sleep, identified by electroencephalogram signs of wakefulness, is an adequate stimulus for ventilation. Importantly, obstructive apneas, such as upper airway collapse in OSA, can be terminated by increased drive to the respiratory muscles not involving cortical arousal.71 For example, hypercarbia resulting from sustained hypopnea69 and elevated upper airway negative pressure22,23 can independently restore tone to the respiratory muscles.
The magnitude of respiratory arousal provided to the respiratory muscles is dependent upon the summation of stimuli in the central respiratory pattern generator output, including peripheral and central chemoresponsiveness, reflex responsiveness to the negative airway pressure, and strength of the “wakefulness” drive. During the perioperative period, respiratory arousal is dampened by sedation, anesthesia, opioids, and endogenous impairment of consciousness. Consequently, the total level of stimulation to respiratory muscles decreases and the upper airway is more vulnerable to collapse and respiratory failure.
Back to Top | Article Outline
Impaired Respiratory Arousal by Endogenous Impairment of Consciousness.
The wakefulness drive to the respiratory muscles can be reduced or eliminated by a variety of perioperative pathologies. Postoperative delirium is a common complication in patients aged more than 65 yr72 and has been associated with failure to wean from the ventilator.73 Stroke is an unfortunate intraoperative complication, with a relatively high incidence following cardiac surgery.74 Strokes directly harm neuronal tissue and can afflict multiple sites, which may affect neuronal transmission of respiratory arousal, thereby causing respiratory muscle weakness that translates to a high incidence of respiratory failure.75 Hypoglycemia,76 hypothyroidism,77 and adrenal insufficiency78 also affect respiratory arousal and can be considered risk factors for respiratory failure in critically ill patients. Thus, endogenous conditions can impair respiratory arousal and are possible contributors to perioperative muscle dysfunction.
Back to Top | Article Outline
Impairment of Respiratory Arousal by Anesthetics, Opioids, and Rapid Eye Movement Sleep Rebound.
Anesthetics, sedatives, and opioids are known respiratory depressants and decrease motor drive to the upper airway dilator and respiratory pump muscles; functionally, they impair respiratory arousal by a variety of mechanisms including reducing chemoresponsiveness to hypoxia and hypercarbia,79–81 suppressing the reflexive responsiveness to negative upper airway pressure,82 and depressing the magnitude of wakefulness. In addition, anesthetics (similar to normal sleep) typically disturb the balance between upper airway dilator muscle and respiratory pump muscle activation upon initiation of unconsciousness.83,84
Back to Top | Article Outline
Anesthetic and Sedative Effects on Respiratory Muscles.
The effects of anesthetics upon respiratory function are dependent upon a variety of factors, including agent, dose, subject’s consciousness, and specific muscle group. Upper airway muscles are generally more affected by sleep, anesthetics, and sedatives than respiratory pump muscles. In 1984, the seminal paper written by Nishino et al.85 described differential effects of anesthetics and sedatives on neural input to upper airway (hypoglossal nerve) and respiratory pump muscles (phrenic nerve) in ventilated, vagotomized cats. Anesthetic and sedative medicines from four classes were tested: volatile (halothane), barbiturate (thiopental), dissociative (ketamine), and benzodiazepine (diazepam). All showed a similar effect on respiratory muscles: decreased stimulation in both nerves. However, whereas halothane, thiopental, and diazepam significantly reduced neural input to upper airway muscles relative to that of the already dampened respiratory pump muscles, ketamine did not. Ketamine reduced the neural input to both the upper airway and respiratory muscles equally, but it reduced the neural input to the upper airway muscles less relative to the other classes of anesthetics.85
Recent animal research suggests that ketamine has no inhibitory effect upon genioglossus activity, but increases genioglossus muscle activity relative to wakefulness, slow wave, and rapid eye movement (REM) sleep.86 Over a wide dose range, ketamine anesthesia maintains activity in the arousal areas of forebrain,87 and it likely stimulates respiration by uncoupling the link between loss of consciousness and upper airway dilator muscle hypotonia.86 Thus, ketamine, unlike other anesthetics, preserves a high level of upper airway dilator muscle activity ordinarily only found with consciousness87; this phenomenon may be in part linked to ketamine’s dose-dependent increase in duty cycle.86 Based on the preclinical data as well as the long-term experience with ketamine as a drug that preserves respiratory function during anesthesia, it may prove to be a safe pharmacological choice for patients with upper airway comorbidities undergoing procedural sedation.
Additional evidence for compound- and muscle-specific effects of anesthetics comes from preclinical studies. In both pentobarbital84,88 and isoflurane,89 anesthetics that initially reduce upper airway muscle activity during the transition from wakefulness to unconsciousness dose dependently promote genioglossus phasic activity relative to the initial reduction. The neural pathways mediating the dose-dependent activating effect of some anesthetics are not fully understood, but considering isoflurane’s genioglossus stimulating effect is abolished in vagotomized rats, the vagus nerve is hypothesized to be the afferent limb.89 Whereas isoflurane in a certain dose range may stimulate both upper airway dilator and respiratory muscles, barbiturates studied in the same model induced a different effect on these respiratory muscles. Pentobarbital increased genioglossus activity, while causing a dose-dependent decrease in diaphragmatic activity.84
Of all anesthetics studied, it appears that propofol has the greatest debilitating effect on the drive to both upper airway dilator and respiratory pump muscles. Compared to an equianesthetic dose of isoflurane, propofol elicited only one third the amount of phasic genioglossus activity in rats, and similarly depressed the drive to the pump muscles,90 effects that could be reversed by conditions that increase the ventilatory drive (i.e., hypoxia and hypercarbia).89
The majority of controlled studies evaluating the effects of anesthetics on the upper airway have been performed on animals. However, the preclinical results lend themselves to well-planned translational studies, which could lead to quality initiatives and the prevention of postoperative respiratory failure. One such study examined airway protection at subhypnotic doses of anesthetics and found that all anesthetics tested compromised pharyngeal function. Furthermore, propofol had the greatest effect upon pharyngeal contraction pattern,91 a finding that agrees with the animal study.89 Another clinical trial92 suggests that ketamine has similar protective effects on ventilatory drive as that observed in preclinical trials.87
Back to Top | Article Outline
Opioid Effects on Respiratory Muscles.
Opioids are the most common postoperative analgesic prescribed,93 and they have a notable adverse effect profile including respiratory depression via upper airway dilator94,95 and respiratory pump muscles96,97 dysfunction. In animal models, opioids impair upper airway muscle function in a dose-dependent fashion.
This effect has been shown through reduced genioglossus activity in rats,94,98,99 decreased vagal motor neuron activity in laryngeal abductors, and increased vagal motor neuron activity in laryngeal adductors.100 These opioid-induced changes result in increased upper airway resistance and possibly vocal cord closure and pharyngeal airflow obstruction.100 It is of clinical importance to note that patients with OSA may be more sensitive to the analgesic effects of opioids and should have doses adjusted accordingly.101,102
The effect of opioids on muscle function extends to those of the respiratory pump including muscles of the thorax and the diaphragm. Chest wall rigidity following opioid administration was first described in 1953,103 and while usually associated with rapid injection, multiple agents, and large doses, it has also occurred when opioids were administered in a conservative fashion.104 Opioid analgesia has also been shown to increase abdominal muscle activity,105 and this persistent expiratory muscle activity produces a rapid decrease in end-expiratory lung volume and FRC, contributing to a higher degree of atelectasis.106 This opioid-induced expiratory muscle recruitment appears not to be related to airway obstruction.107 Even the diaphragm is affected. In spontaneously ventilating rats, high-dose opioids led to diaphragm dysfunction and a reduction in phasic activity, leading to reduced tidal volume and minute ventilation;96 similar effects have been seen in felines.100
Back to Top | Article Outline
REM Rebound Effect on Respiratory Muscles.
Both surgery and anesthetics can affect sleep structure. Sleep following surgery is typically fragmented, reduced, and lacking in REM sleep.108,109 The absence of REM sleep leads to a REM sleep deficit, and this deficit can only be repaid by increasing REM sleep relative to non-REM stages in subsequent nights.110 Consequently, REM sleep returns abruptly a few nights after surgery in greater intensity and quantity than usual.111
During REM sleep, there is persistent voluntary muscle hypotonia, and electromyogram activity is at its lowest level of any stage of sleep.112 Accordingly, the neural drive to the upper airway dilators is decreased and this relative hypotonia predisposes the patient to airway instability, leading to episodic hypoxemia.113 In addition to the anatomic changes in the upper airway, REM affects respiratory physiology including reducing both the hypoxic ventilatory drive and the hypercarbic ventilatory response.112 Thus, the postoperative return of REM sleep, labeled REM rebound, results in an even greater number of episodes of hypoxemia secondary to impaired respiratory arousal.114
However, not all surgeries and not all anesthetics have this effect. For surgery, the severity of the procedure performed affects loss of REM sleep115 and implicitly the incidence of REM rebound. This concept holds true with minimally invasive surgery, as a laparoscopic cholecystectomy appears to have less effect upon postoperative REM quality and quantity than major abdominal surgery.116
As for anesthesia, different anesthetics and lengths of exposure have different effects upon REM sleep. For example, whereas 6 h of either isoflurane, sevoflurane, or halothane anesthesia caused both a REM deficit and REM rebound in mice,117 3 h of isoflurane general anesthesia in nonsurgical volunteers had no effect upon REM.118 Benzodiazepines as a class reduce REM sleep and are known to cause REM rebound upon discontinuation.119 On the opposite end of the spectrum is propofol which in preclinical trials appears to cause neither REM deficit120 nor REM rebound.121
Accordingly, choice of anesthetic may help reduce occurrences of postoperative apnea both in the near term from immediate effects of anesthetics on the upper airway dilators and in the days into recovery by reducing or eliminating REM rebound.109
Back to Top | Article Outline
Neuromuscular Blocking Agents (Postoperative Residual Curarization)
Pharmacologic muscle relaxation through neuromuscular blocking agents (NMBA) is helpful to optimize surgical conditions. Following completion of the procedure, patients often have this chemical paralysis reversed, but postoperative residual curarization frequently persists.122 There is strong evidence that postoperative residual curarization not only results in physiologic impairment,16,17,123,124 but also places patients at increased perioperative risk8,124,125 and may increase costs.126 Additionally, even patients whose “train of four” ratio is just less than unity still show significant distortion in their upper airway anatomy and function.123
It is well documented in preclinical and clinical trials that upper airway dilators are disproportionately sensitive to the effects of NMBA than the diaphragm,123,127,128 and, similar to sleep,129 the retropalatal region is the most collapsible part in the upper airway.123 In healthy volunteers, even minimal neuromuscular blockade is associated with impairment of upper airway dilator muscle function, resulting in increased upper airway closing pressures and greater risk of collapse.123,124 Even the use of modern intermediate-acting NMBA predicts an increased risk of postoperative desaturation as well as reintubation requiring unplanned admission to an intensive care unit.14 Interestingly, increased upper airway closing pressures were also seen in healthy volunteers, who, after fully recovering from pharmacological paralysis, were administered reversal agents (neostigmine and glycopyrrolate),130 and neostigmine reversal was also associated with increased postoperative respiratory complications.14 These studies suggest that acetylcholinesterase inhibitor-based reversal agents can trigger the very symptomatology they are intended to prevent.14,130
Increased upper airway collapsibility may predispose patients to respiratory failure, particularly when coupled with other airway comorbidities such as obesity or increased airway secretions.8,15 Additionally, postoperative residual curarization may cause negative pressure pulmonary edema secondary to excessive negative intrathoracic pressures generated by respiratory pump muscles contracting in the setting of upper airway obstruction.131 Postoperative residual curarization may also lead to respiratory failure via increased aspiration risk secondary to impaired swallow reflexes.17
Accordingly, it is important to titrate NMBA carefully by using quantitative neuromuscular transmission monitoring. In addition, future goals for reducing the respiratory risks of non-depolarizing NMBA include the development and use of shorter-acting NMBA and new reversal agents that directly halt the effects of NMBA such that skeletal muscle strength can be fully restored at the end of the case.
Back to Top | Article Outline
Systemic Inflammation
Systemic inflammation, whether a preoperative condition, a product of trauma,132 or the surgery alone,133 can have a serious effect upon the respiratory system. Traditionally, inflammation is associated with increased ventilatory effort due to increased metabolic demands, and direct cytotoxic effects upon the respiratory system.
Back to Top | Article Outline
Imbalance between Energy Supplies and Oxygen Consumption.
Systemic inflammation places a patient into a catabolic state and a patient’s metabolic demands markedly increase,134 resulting in downstream effects of increased respiratory drive, increased respiratory pump work, and increased oxygen consumption. Both an animal model135 and an observational study136 have shown that severe, systemic inflammation can lead to body oxygen demand outstripping oxygen stores and leading to depressed performance of respiratory pump muscles and respiratory failure. Furthermore, the resulting lactate acidosis may also directly affect diaphragmatic contractility.137
Back to Top | Article Outline
Cytotoxic Effects of Inflammatory Mediators.
In the setting of systemic inflammation, inflammatory mediators nitric oxide and tumor necrosis factor-α have been linked to respiratory muscle weakness, which contributes to severe sepsis-associated respiratory failure.138–141
Back to Top | Article Outline
Mechanical Ventilation
Approximately 20–30% of patients have trouble weaning from prolonged mechanical ventilation142 and this leads to increased healthcare costs.143 Failure of respiratory pump muscles is a contributing factor to weaning delays.144,145 Furthermore, controlled mechanical ventilation immobilizes the diaphragm and directly harms diaphragm function,146–148 causing ventilator-induced diaphragmatic dysfunction and adding to the conditions perpetuating the respiratory failure.
Controlled ventilation is associated with the rapid onset of proteolysis in the diaphragm, leading to atrophy and diaphragm dysfunction in preclinical146,149 and clinical studies.147,148 Only 18 h of controlled ventilation resulted in diaphragm atrophy and contractile dysfunction in both laboratory animals146 and humans.147 Additionally, length of time on controlled ventilation is positively correlated with diaphragmatic thinning150 as well as injury and atrophy.148 Controlled ventilation appears to be a dose-dependent contributor to respiratory pump muscle dysfunction and may be responsible for delayed weaning from mechanical ventilation.
The addition of NMBA to controlled ventilation, in an attempt to reduce work of breathing and transpulmonary pressure (PL), and improve ventilatory synchrony, can further harm respiratory muscles making a risk–benefit assessment critical before prescribing NMBA in the setting of acute respiratory distress syndrome. The use of NMBA has been associated with intensive care unit-acquired weakness151–154—a condition linked to delayed weaning of mechanical ventilation.155 The paralytic effects of NMBA persist long after their final dosing, with paralysis continuing from 6 h to 7 days in 44% of a group of critically ill patients treated with vecuronium.156 Additionally, NMBA may compound the diaphragmatic damage done by mechanical ventilation; in rats, rocuronium with controlled ventilation has been linked to even greater diaphragmatic dysfunction than mechanical ventilation with placebo.157
Finally, NMBA block muscle function and eliminate volitional mobility. Physical mobilization historically has been associated with improved respiratory function.158 Recent studies focusing on early mobilization have linked it to fewer ventilator days159 and shorter intensive care unit and hospital lengths of stay.160 Moreover, comprehensive early pulmonary rehabilitation consisting of inspiratory muscle training combined with early mobilization improved the 6-min walk distance, a fundamental measure of rehabilitation.161 Early mobilization and pulmonary rehabilitation are likely cost-effective methods of improving respiratory outcomes. Recent data suggest that these data gathered in the medical intensive care units translate also to perioperative patients.162
Back to Top | Article Outline
Preoperative Respiratory Morbidity
Respiratory muscle function can be affected in the postoperative period by patients’ comorbid conditions unrelated to the operation.
Back to Top | Article Outline
Age.
Aging is an important preoperative predictor of the development of PPC163 as it leads to reduced elastic recoil of the lung,164 reduced chest wall compliance,165 and decreased diaphragmatic strength.166 These anatomic changes can impair gas exchange and increase work of breathing, thus leading to vulnerability to respiratory muscle fatigue, and impaired upper airway patency.167 Furthermore, elderly patients are more sensitive to respiratory depressants168 because of both decreased responsiveness to hypercarbia and hypoxemia,169 and decreased metabolic clearance of anesthetics and opioids.168 In combination, the anatomic and physiologic changes brought about by aging predispose the aged to respiratory muscle dysfunction in the perioperative setting.
Back to Top | Article Outline
Obesity.
Over one third of the American adult population and one fifth of our children qualify as obese: obesity is an omnipresent health problem.170 Obesity affects both upper airway dilator and respiratory pump muscles. In the upper airway, obesity is associated with increased adipose around the pharyngeal airway which can overcome upper airway dilator muscles’ efforts at maintaining patency.171 This increased pharyngeal soft tissue in obese subjects predisposes the upper airway to collapse,172 whereas in nonobese subjects, even during complete muscle paralysis through NMBA, the upper airway still requires -4 cm H2O to collapse.173 The excess truncal and abdominal adipose tissue found in obese subjects impedes the respiratory pump muscles by increasing the work required to expand the thorax during inspiration, thus leading to lower flow and volume.174 Obese subjects also have an increased work of breathing compared with nonobese controls as demonstrated by a 16% reduction in oxygen consumption when obese subjects were placed on mechanical ventilation compared to no change with nonobese subjects.175
Back to Top | Article Outline
Obstructive Sleep Apnea.
Body weight and obesity are strongly associated with OSA.176 OSA is an increasingly common chronic disease in developed and rapidly developing nations, with a prevalence estimate of 3–7% in men and 1–4% in women;177 this gender discrepancy may partially be related to women’s more robust respiratory arousal elicited by negative pressures in the upper airway.178 Along with obesity and male gender, OSA risk factors include aging,167 smoking and alcohol consumption, craniofacial anatomy, and sundry heritable factors.177
Fig. 4
Fig. 4
Image Tools
In patients with OSA, upper airway obstruction during the perioperative period can result from alterations in either the passive structural pharyngeal properties or impaired respiratory arousal. During inspiration and expiration, the genioglossus muscle has significantly more activity in subjects with OSA than in control subjects.179 However, the onset of sleep changes the control of the upper airway muscles. Specifically, the negative-pressure reflex resulting in increased upper airway contraction is substantially reduced during non-REM sleep and even further reduced during REM sleep.180,181 Additionally, the “wakefulness” input to these muscles is lessened during sleep,70 leaving the upper airway particularly vulnerable to collapse. Continuous positive airway pressure (CPAP) is the definitive standard treatment for OSA patients during sleep,182 and CPAP has the potential to improve perioperative conditions as well183 (fig. 4). Furthermore, usage of CPAP in the postoperative period may allow more patients with OSA to have ambulatory surgery rather than requiring overnight admission for respiratory observation.184,185
Back to Top | Article Outline
Obstructive Respiratory Pathology.
Asthma and chronic obstructive pulmonary disease are two common respiratory pathologies and have been diagnosed in approximately 13 and 6% of American adults, respectively.186 Both chronic obstructive pulmonary disease and asthma can lead to a pathologic increase in FRC termed hyperinflation. Hyperinflation prevents optimal generation of negative intrathoracic pressure through a variety of mechanisms—most affecting diaphragmatic function,187–190 which may be an important pathophysiologic mechanism in the predisposition of chronic obstructive pulmonary disease patients to develop perioperative respiratory failure.191
Back to Top | Article Outline
Smoking.
Active smoking is an independent risk factor for PPC.192 Smoking increases airway hypersensitivity to chemical stimulants including desflurane,193 retards pulmonary immune system defenses against infection,194,195 and increases respiratory mucus production.196 Together these changes further reduce a patient’s physiological reserve to respond to perioperative respiratory challenges.
Back to Top | Article Outline

Strategies to Prevent Postoperative Respiratory Failure

Postoperative hypoxemia complicates 30–50% of abdominal surgeries, and up to 8–10% of these patients require reintubation and mechanical ventilation.197 Statistics such as these inspire research to predict which patients may need reintubation based on a variety of perioperative risk factors. The ideal algorithm for predicting the likelihood of reintubation would be based on preoperative characteristics198 so patients could be triaged to appropriate postsurgical level of care. Furthermore, intraoperative events could be considered alongside a validated pretest probability, and only high-risk patients would be conservatively sent to higher care and higher cost units. Perioperative characteristics that have been associated with respiratory failure, and could be considered for an algorithm, include the following: American Society of Anesthesiologists physical status score, comorbid disorders, dependent functional status, emergency case, and type of surgery.3,6,46,198
Table 1
Table 1
Image Tools
Although predicting the likelihood of reintubation assists in the proper allocation of resources, preventing reintubation is the genuine goal and can be done by maintaining patients’ respiratory muscle function. A summary of preventative strategies for preserving respiratory muscle function can be found in table 1.
The effort to improve postoperative respiratory muscle function and avoid respiratory failure begins with surgical and anesthetic planning: minimally invasive techniques56,116,199 and regional anesthesia for pain aggravated by breathing200 should be utilized when indicated. Regional anesthesia for postoperative pain control can result in improved pulmonary function. First, regional anesthesia can provide better overall pain control than intravenous administration of opioids201 and potentially allow for deeper breaths and earlier ambulation. Additionally, regional anesthesia improves diaphragm muscle activity, likely by blocking nerves associated with an inhibitory reflex,202 and increases FRC, through the caudal motion of the diaphragm and a decrease in the intrathoracic blood volume.203 In total, these improvements in pain control and postoperative lung function may translate to decreased incidence of PPC.204
Furthermore, long-acting paralytics must be avoided,15 and both paralytics8,124,125 and reversal agents127 must be precisely dosed and monitored by quantitative neuromuscular transmission monitoring.
In the setting of decreased efficiency of respiratory muscle contractions, such as flail chest, intraabdominal hypertension, and bronchial hyperreactivity, consider basing treatment on the property of the conditions; for example, open reduction with internal fixation and regional anesthesia for flail chest,200,205 fluid restriction and decompression for intraabdominal hypertension,65,206,207 and rigorous bronchodilator treatment and noninvasive ventilation for bronchial hyperreactivity.208,209 During periods of systemic inflammation with increased respiratory effort, identify and treat the underlying cause early.210 Following any procedure, multimodal analgesic strategies to decrease opioid-induced respiratory muscle weakness should be employed.211
For obese patients with the diagnosis of OSA, and probably those without,212 postoperative CPAP may reduce the risk of pulmonary complications.183 Substituting CPAP and other forms of noninvasive mechanical ventilation may also be beneficial for patients with postoperative hypoxia or hypoventilation not requiring airway protection.208,213
Fig. 5
Fig. 5
Image Tools
When a patient is maintained on mechanical ventilation postoperatively or develops acute respiratory distress syndrome, it is important to minimize the immobilizing effect of mechanical ventilation on the respiratory muscles147,157 and encourage passive mobilization as an initial step in pulmonary rehabilitation161 (fig. 5). Therefore, spontaneous breathing efforts should be trialed while keeping the transpulmonary pressure (PL) in mind.214 PL is defined as the difference between airway plateau pressure (PPlat) and pleural pressure (PPL), and it varies with respiratory pump effort when PPlat is constant.215 Most importantly, increases in PL from high respiratory effort and aggressive spontaneous breathing can result in barotrauma.216,217
One approach to managing PL is utilizing controlled ventilation and prescribing NMBA216,218; however, it is important to avoid immobilizing the diaphragm unnecessarily,157 especially when initial attempts to control PL can be made through titration and selection of sedatives and analgesics. Furthermore, partial support ventilatory modes that permit spontaneous breathing should be utilized as they reduce diaphragmatic harm in preclinical trials219–221 and improve ventilation perfusion matching in clinical studies.222,223
Back to Top | Article Outline

Conclusion

Proper respiratory muscle dysfunction is a key determinant of postoperative respiratory failure. Careful attention should be paid to the effect of perioperative interventions on respiratory muscles, particularly in patients at risk of postoperative respiratory failure. The type of surgical procedure, the anesthesia plan, the postoperative pain management, and the mechanical ventilation strategy can all incrementally push a patient toward or away from upper airway collapse or respiratory pump dysfunction: both of which increase the likelihood of postoperative respiratory failure.
Back to Top | Article Outline

References

1. Money SR, Rice K, Crockett D, Becker M, Abdoh A, Wisselink W, Kazmier F, Hollier L. Risk of respiratory failure after repair of thoracoabdominal aortic aneurysms. Am J Surg. 1994;168:152–5

2. Filsoufi F, Rahmanian PB, Castillo JG, Chikwe J, Adams DH. Predictors and early and late outcomes of respiratory failure in contemporary cardiac surgery. Chest. 2008;133:713–21

3. Johnson RG, Arozullah AM, Neumayer L, Henderson WG, Hosokawa P, Khuri SF. Multivariable predictors of postoperative respiratory failure after general and vascular surgery: Results from the patient safety in surgery study. J Am Coll Surg. 2007;204:1188–98

4. Khuri SF, Henderson WG, DePalma RG, Mosca C, Healey NA, Kumbhani DJ. Determinants of long-term survival after major surgery and the adverse effect of postoperative complications. Ann Surg. 2005;242:326–41; discussion 341–3

5. Dimick JB, Chen SL, Taheri PA, Henderson WG, Khuri SF, Campbell DA Jr. Hospital costs associated with surgical complications: A report from the private-sector National Surgical Quality Improvement Program. J Am Coll Surg. 2004;199:531–7

6. Arozullah AM, Daley J, Henderson WG, Khuri SF. Multifactorial risk index for predicting postoperative respiratory failure in men after major noncardiac surgery. The National Veterans Administration Surgical Quality Improvement Program. Ann Surg. 2000;232:242–53

7. Eikermann M, Blobner M, Groeben H, Rex C, Grote T, Neuhäuser M, Beiderlinden M, Peters J. Postoperative upper airway obstruction after recovery of the train of four ratio of the adductor pollicis muscle from neuromuscular blockade. Anesth Analg. 2006;102:937–42

8. Murphy GS, Szokol JW, Marymont JH, Greenberg SB, Avram MJ, Vender JS. Residual neuromuscular blockade and critical respiratory events in the postanesthesia care unit. Anesth Analg. 2008;107:130–7

9. Cook TM, Woodall N, Frerk CFourth National Audit Project. . Major complications of airway management in the UK: Results of the Fourth National Audit Project of the Royal College of Anaesthetists and the Difficult Airway Society. Part 1: Anaesthesia. Br J Anaesth. 2011;106:617–31

10. Bolden N, Smith CE, Auckley D, Makarski J, Avula R. Perioperative complications during use of an obstructive sleep apnea protocol following surgery and anesthesia. Anesth Analg. 2007;105:1869–70

11. Warner MA, Warner ME, Weber JG. Clinical significance of pulmonary aspiration during the perioperative period. ANESTHESIOLOGY. 1993;78:56–62

12. Hong JJ, Cohn SM, Perez JM, Dolich MO, Brown M, McKenney MG. Prospective study of the incidence and outcome of intra-abdominal hypertension and the abdominal compartment syndrome. Br J Surg. 2002;89:591–6

13. Runck H, Schumann S, Tacke S, Haberstroh J, Guttmann J. Effects of intra-abdominal pressure on respiratory system mechanics in mechanically ventilated rats. Respir Physiol Neurobiol. 2012;180:204–10

14. Grosse-Sundrup M, Henneman JP, Sandberg WS, Bateman BT, Uribe JV, Nguyen NT, Ehrenfeld JM, Martinez EA, Kurth T, Eikermann M. Intermediate acting non-depolarizing neuromuscular blocking agents and risk of postoperative respiratory complications: Prospective propensity score matched cohort study. BMJ. 2012;345:e6329

15. Berg H, Roed J, Viby-Mogensen J, Mortensen CR, Engbaek J, Skovgaard LT, Krintel JJ. Residual neuromuscular block is a risk factor for postoperative pulmonary complications. A prospective, randomised, and blinded study of postoperative pulmonary complications after atracurium, vecuronium and pancuronium. Acta Anaesthesiol Scand. 1997;41:1095–103

16. Eikermann M, Groeben H, Hüsing J, Peters J. Accelerometry of adductor pollicis muscle predicts recovery of respiratory function from neuromuscular blockade. ANESTHESIOLOGY. 2003;98:1333–7

17. Sundman E, Witt H, Olsson R, Ekberg O, Kuylenstierna R, Eriksson LI. The incidence and mechanisms of pharyngeal and upper esophageal dysfunction in partially paralyzed humans: Pharyngeal videoradiography and simultaneous manometry after atracurium. ANESTHESIOLOGY. 2000;92:977–84

18. McCool FD. Global physiology and pathophysiology of cough: ACCP evidence-based clinical practice guidelines. Chest. 2006;129:48S–53S

19. Bach JR. Amyotrophic lateral sclerosis: Prolongation of life by noninvasive respiratory AIDS. Chest. 2002;122:92–8

20. Hulzebos EH, Helders PJ, Favié NJ, De Bie RA, Brutel de la Riviere A, Van Meeteren NL. Preoperative intensive inspiratory muscle training to prevent postoperative pulmonary complications in high-risk patients undergoing CABG surgery: A randomized clinical trial. JAMA. 2006;296:1851–7

21. Butler JE. Drive to the human respiratory muscles. Respir Physiol Neurobiol. 2007;159:115–26

22. Pierce R, White D, Malhotra A, Edwards JK, Kleverlaan D, Palmer L, Trinder J. Upper airway collapsibility, dilator muscle activation and resistance in sleep apnoea. Eur Respir J. 2007;30:345–53

23. Chamberlin NL, Eikermann M, Fassbender P, White DP, Malhotra A. Genioglossus premotoneurons and the negative pressure reflex in rats. J Physiol (Lond). 2007;579:515–26

24. Nicholas CL, Jordan AS, Heckel L, Worsnop C, Bei B, Saboisky JP, Eckert DJ, White DP, Malhotra A, Trinder J. Discharge patterns of human tensor palatini motor units during sleep onset. Sleep. 2012;35:699–707

25. Isono S, Tanaka A, Tagaito Y, Sho Y, Nishino T. Pharyngeal patency in response to advancement of the mandible in obese anesthetized persons. ANESTHESIOLOGY. 1997;87:1055–62

26. Watanabe T, Isono S, Tanaka A, Tanzawa H, Nishino T. Contribution of body habitus and craniofacial characteristics to segmental closing pressures of the passive pharynx in patients with sleep-disordered breathing. Am J Respir Crit Care Med. 2002;165:260–5

27. Isono S, Tanaka A, Nishino T. Lateral position decreases collapsibility of the passive pharynx in patients with obstructive sleep apnea. ANESTHESIOLOGY. 2002;97:780–5

28. Tagaito Y, Isono S, Tanaka A, Ishikawa T, Nishino T. Sitting posture decreases collapsibility of the passive pharynx in anesthetized paralyzed patients with obstructive sleep apnea. ANESTHESIOLOGY. 2010;113:812–8

29. Itasaka Y, Miyazaki S, Ishikawa K, Togawa K. The influence of sleep position and obesity on sleep apnea. Psychiatry Clin Neurosci. 2000;54:340–1

30. Schneider H, Krishnan V, Pichard LE, Patil SP, Smith PL, Schwartz AR. Inspiratory duty cycle responses to flow limitation predict nocturnal hypoventilation. Eur Respir J. 2009;33:1068–76

31. Sériès F, Marc I. Influence of lung volume dependence of upper airway resistance during continuous negative airway pressure. J Appl Physiol. 1994;77:840–4

32. Hoffstein V, Zamel N, Phillipson EA. Lung volume dependence of pharyngeal cross-sectional area in patients with obstructive sleep apnea. Am Rev Respir Dis. 1984;130:175–8

33. Van de Graaff WB. Thoracic influence on upper airway patency. J Appl Physiol. 1988;65:2124–31

34. Van de Graaff WB. Thoracic traction on the trachea: Mechanisms and magnitude. J Appl Physiol. 1991;70:1328–36

35. Shiota S, Ryan CM, Chiu KL, Ruttanaumpawan P, Haight J, Arzt M, Floras JS, Chan C, Bradley TD. Alterations in upper airway cross-sectional area in response to lower body positive pressure in healthy subjects. Thorax. 2007;62:868–72

36. Su MC, Chiu KL, Ruttanaumpawan P, Shiota S, Yumino D, Redolfi S, Haight JS, Bradley TD. Lower body positive pressure increases upper airway collapsibility in healthy subjects. Respir Physiol Neurobiol. 2008;161:306–12

37. Redolfi S, Arnulf I, Pottier M, Lajou J, Koskas I, Bradley TD, Similowski T. Attenuation of obstructive sleep apnea by compression stockings in subjects with venous insufficiency. Am J Respir Crit Care Med. 2011;184:1062–6

38. Yumino D, Redolfi S, Ruttanaumpawan P, Su MC, Smith S, Newton GE, Mak S, Bradley TD. Nocturnal rostral fluid shift: A unifying concept for the pathogenesis of obstructive and central sleep apnea in men with heart failure. Circulation. 2010;121:1598–605

39. Mead J, Loring SH. Analysis of volume displacement and length changes of the diaphragm during breathing. J Appl Physiol. 1982;53:750–5

40. Muller NL, Francis PW, Gurwitz D, Levison H, Bryan AC. Mechanism of hemoglobin desaturation during rapid-eye-movement sleep in normal subjects and in patients with cystic fibrosis. Am Rev Respir Dis. 1980;121:463–9

41. Muller N, Volgyesi G, Becker L, Bryan MH, Bryan AC. Diaphragmatic muscle tone. J Appl Physiol. 1979;47:279–84

42. de Troyer A, Bastenier J, Delhez L. Function of respiratory muscles during partial curarization in humans. J Appl Physiol. 1980;49:1049–56

43. Wade OL. Movements of the thoracic cage and diaphragm in respiration. J Physiol (Lond). 1954;124:193–212

44. Sasaki H, Hida W, Takishima T. Influence of body position on dynamic compliance in young subjects. J Appl Physiol. 1977;42:706–10

45. Sharp JT, Goldberg NB, Druz WS, Danon J. Relative contributions of rib cage and abdomen to breathing in normal subjects. J Appl Physiol. 1975;39:608–18

46. Gupta H, Gupta PK, Fang X, Miller WJ, Cemaj S, Forse RA, Morrow LE. Development and validation of a risk calculator predicting postoperative respiratory failure. Chest. 2011;140:1207–15

47. McAlister FA, Khan NA, Straus SE, Papaioakim M, Fisher BW, Majumdar SR, Gajic O, Daniel M, Tomlinson G. Accuracy of the preoperative assessment in predicting pulmonary risk after nonthoracic surgery. Am J Respir Crit Care Med. 2003;167:741–4

48. Mitchell CK, Smoger SH, Pfeifer MP, Vogel RL, Pandit MK, Donnelly PJ, Garrison RN, Rothschild MA. Multivariate analysis of factors associated with postoperative pulmonary complications following general elective surgery. Arch Surg. 1998;133:194–8

49. Ali J, Weisel RD, Layug AB, Kripke BJ, Hechtman HB. Consequences of postoperative alterations in respiratory mechanics. Am J Surg. 1974;128:376–82

50. Meyers JR, Lembeck L, O’Kane H, Baue AE. Changes in functional residual capacity of the lung after operation. Arch Surg. 1975;110:576–83

51. Ford GT, Whitelaw WA, Rosenal TW, Cruse PJ, Guenter CA. Diaphragm function after upper abdominal surgery in humans. Am Rev Respir Dis. 1983;127:431–6

52. Simonneau G, Vivien A, Sartene R, Kunstlinger F, Samii K, Noviant Y, Duroux P. Diaphragm dysfunction induced by upper abdominal surgery. Role of postoperative pain. Am Rev Respir Dis. 1983;128:899–903

53. Merino-Ramirez MA, Juan G, Ramón M, Cortijo J, Rubio E, Montero A, Morcillo EJ. Electrophysiologic evaluation of phrenic nerve and diaphragm function after coronary bypass surgery: Prospective study of diabetes and other risk factors. J Thorac Cardiovasc Surg. 2006;132:530–6, 536.e1–2

54. Lindell P, Hedenstierna G. Ventilation efficiency after different incisions for cholecystectomy. Acta Chir Scand. 1976;142:561–5

55. Elman A, Langonnet F, Dixsaut G, Hay JM, Guignard J, Dazza F, Maillard JN. Respiratory function is impaired less by transverse than by median vertical supraumbilical incisions. Intensive Care Med. 1981;7:235–9

56. Rademaker BM, Ringers J, Odoom JA, de Wit LT, Kalkman CJ, Oosting J. Pulmonary function and stress response after laparoscopic cholecystectomy: Comparison with subcostal incision and influence of thoracic epidural analgesia. Anesth Analg. 1992;75:381–5

57. Toledo-Pereyra LH, DeMeester TR. Prospective randomized evaluation of intrathoracic intercostal nerve block with bupivacaine on postoperative ventilatory function. Ann Thorac Surg. 1979;27:203–5

58. Ali J, Yaffe CS, Serrette C. The effect of transcutaneous electric nerve stimulation on postoperative pain and pulmonary function. Surgery. 1981;89:507–12

59. Craig DB. Postoperative recovery of pulmonary function. Anesth Analg. 1981;60:46–52

60. Berdah SV, Picaud R, Jammes Y. Surface diaphragmatic electromyogram changes after laparotomy. Clin Physiol Funct Imaging. 2002;22:157–60

61. Krause KM, Moody MR, Andrade FH, Taylor AA, Miller CC 3rd, Kobzik L, Reid MB. Peritonitis causes diaphragm weakness in rats. Am J Respir Crit Care Med. 1998;157:1277–82

62. Ford GT, Grant DA, Rideout KS, Davison JS, Whitelaw WA. Inhibition of breathing associated with gallbladder stimulation in dogs. J Appl Physiol. 1988;65:72–9

63. Malbrain ML, Chiumello D, Pelosi P, Wilmer A, Brienza N, Malcangi V, Bihari D, Innes R, Cohen J, Singer P, Japiassu A, Kurtop E, De Keulenaer BL, Daelemans R, Del Turco M, Cosimini P, Ranieri M, Jacquet L, Laterre PF, Gattinoni L. Prevalence of intra-abdominal hypertension in critically ill patients: a multicentre epidemiological study. Intensive Care Med. 2004;30:822–9

64. Hall AB, Northern D. Effect of abdominal binders on pulmonary mechanics with implications for the military surgical population. J Surg Educ. 2012;69:34–6

65. Mutoh T, Lamm WJ, Embree LJ, Hildebrandt J, Albert RK. Volume infusion produces abdominal distension, lung compression, and chest wall stiffening in pigs. J Appl Physiol. 1992;72:575–82

66. Ciraulo DL, Elliott D, Mitchell KA, Rodriguez A. Flail chest as a marker for significant injuries. J Am Coll Surg. 1994;178:466–70

67. Duff JH, Goldstein M, McLean AP, Agrawal SN, Munro DD, Gutelius JR. Flail chest: A clinical review and physiological study. J Trauma. 1968;8:63–74

68. Berry RB, Gleeson K. Respiratory arousal from sleep: Mechanisms and significance. Sleep. 1997;20:654–75

69. Pattinson KT. Opioids and the control of respiration. Br J Anaesth. 2008;100:747–58

70. Lo YL, Jordan AS, Malhotra A, Wellman A, Heinzer RA, Eikermann M, Schory K, Dover L, White DP. Influence of wakefulness on pharyngeal airway muscle activity. Thorax. 2007;62:799–805

71. Jordan AS, Eckert DJ, Wellman A, Trinder JA, Malhotra A, White DP. Termination of respiratory events with and without cortical arousal in obstructive sleep apnea. Am J Respir Crit Care Med. 2011;184:1183–91

72. Mackensen GB, Gelb AW. Postoperative cognitive deficits: More questions than answers. Eur J Anaesthesiol. 2004;21:85–8

73. Stransky M, Schmidt C, Ganslmeier P, Grossmann E, Haneya A, Moritz S, Raffer M, Schmid C, Graf BM, Trabold B. Hypoactive delirium after cardiac surgery as an independent risk factor for prolonged mechanical ventilation. J Cardiothorac Vasc Anesth. 2011;25:968–74

74. Hogue CW Jr, Murphy SF, Schechtman KB, Dávila-Román VG. Risk factors for early or delayed stroke after cardiac surgery. Circulation. 1999;100:642–7

75. Knapik P, Ciesla D, Borowik D, Czempik P, Knapik T. Prolonged ventilation post cardiac surgery–tips and pitfalls of the prediction game. J Cardiothorac Surg. 2011;6:158

76. Baig MA, Ali S, Rasheed J, Bergman M, Privman V. Severe hypoglycemia in a nondiabetic patient leading to acute respiratory failure. J Natl Med Assoc. 2006;98:1362–4

77. Boyd DW, Brewis RA, Gleeson MH. Myxoedema coma. Postgrad Med J. 1969;45:342–4

78. de Lind van Wijngaarden RF, Joosten KF, van den Berg S, Otten BJ, de Jong FH, Sweep CG, de Weerd AW, Hokken-Koelega AC. The relationship between central adrenal insufficiency and sleep-related breathing disorders in children with Prader-Willi syndrome. J Clin Endocrinol Metab. 2009;94:2387–93

79. Hwang JC, St John WM, Bartlett D Jr. Respiratory-related hypoglossal nerve activity: Influence of anesthetics. J Appl Physiol. 1983;55:785–92

80. Zhang Z, Zhuang J, Zhang C, Xu F. Activation of opioid μ-receptors in the commissural subdivision of the nucleus tractus solitarius abolishes the ventilatory response to hypoxia in anesthetized rats. ANESTHESIOLOGY. 2011;115:353–63

81. Zhang Z, Xu F, Zhang C, Liang X. Activation of opioid mu receptors in caudal medullary raphe region inhibits the ventilatory response to hypercapnia in anesthetized rats. ANESTHESIOLOGY. 2007;107:288–97

82. Eastwood PR, Szollosi I, Platt PR, Hillman DR. Collapsibility of the upper airway during anesthesia with isoflurane. ANESTHESIOLOGY. 2002;97:786–93

83. Drummond GB. Influence of thiopentone on upper airway muscles. Br J Anaesth. 1989;63:12–21

84. Eikermann M, Fassbender P, Zaremba S, Jordan AS, Rosow C, Malhotra A, Chamberlin NL. Pentobarbital dose-dependently increases respiratory genioglossus muscle activity while impairing diaphragmatic function in anesthetized rats. ANESTHESIOLOGY. 2009;110:1327–34

85. Nishino T, Shirahata M, Yonezawa T, Honda Y. Comparison of changes in the hypoglossal and the phrenic nerve activity in response to increasing depth of anesthesia in cats. ANESTHESIOLOGY. 1984;60:19–24

86. Eikermann M, Grosse-Sundrup M, Zaremba S, Henry ME, Bittner EA, Hoffmann U, Chamberlin NL. Ketamine activates breathing and abolishes the coupling between loss of consciousness and upper airway dilator muscle dysfunction. ANESTHESIOLOGY. 2012;116:35–46

87. Lu J, Nelson LE, Franks N, Maze M, Chamberlin NL, Saper CB. Role of endogenous sleep-wake and analgesic systems in anesthesia. J Comp Neurol. 2008;508:648–62

88. Eikermann M, Eckert DJ, Chamberlin NL, Jordan AS, Zaremba S, Smith S, Rosow C, Malhotra A. Effects of pentobarbital on upper airway patency during sleep. Eur Respir J. 2010;36:569–76

89. Eikermann M, Malhotra A, Fassbender P, Zaremba S, Jordan AS, Gautam S, White DP, Chamberlin NL. Differential effects of isoflurane and propofol on upper airway dilator muscle activity and breathing. ANESTHESIOLOGY. 2008;108:897–906

90. Eastwood PR, Platt PR, Shepherd K, Maddison K, Hillman DR. Collapsibility of the upper airway at different concentrations of propofol anesthesia. ANESTHESIOLOGY. 2005;103:470–7

91. Sundman E, Witt H, Sandin R, Kuylenstierna R, Bodén K, Ekberg O, Eriksson LI. Pharyngeal function and airway protection during subhypnotic concentrations of propofol, isoflurane, and sevoflurane: Volunteers examined by pharyngeal videoradiography and simultaneous manometry. ANESTHESIOLOGY. 2001;95:1125–32

92. Drummond GB. Comparison of sedation with midazolam and ketamine: Effects on airway muscle activity. Br J Anaesth. 1996;76:663–7

93. Dahan A, Aarts L, Smith TW. Incidence, reversal, and prevention of opioid-induced respiratory depression. ANESTHESIOLOGY. 2010;112:226–38

94. Hajiha M, DuBord MA, Liu H, Horner RL. Opioid receptor mechanisms at the hypoglossal motor pool and effects on tongue muscle activity in vivo. J Physiol. 2009;587:2677–92

95. Overdyk FJ. Postoperative opioids remain a serious patient safety threat. ANESTHESIOLOGY. 2010;113:259–60; author reply 260–1

96. Campbell C, Weinger MB, Quinn M. Alterations in diaphragm EMG activity during opiate-induced respiratory depression. Respir Physiol. 1995;100:107–17

97. Horrow JC, Abrams JT, Van Riper DF, Lambson DL, Storella RJ. Ventilatory compliance after three sufentanil-pancuronium induction sequences. ANESTHESIOLOGY. 1991;75:969–74

98. Skulsky EM, Osman NI, Baghdoyan HA, Lydic R. Microdialysis delivery of morphine to the hypoglossal nucleus of Wistar rat increases hypoglossal acetylcholine release. Sleep. 2007;30:566–73

99. Liu X, Sood S, Liu H, Horner RL. Opposing muscarinic and nicotinic modulation of hypoglossal motor output to genioglossus muscle in rats in vivo. J Physiol (Lond). 2005;565:965–80

100. Lalley PM. Mu-opioid receptor agonist effects on medullary respiratory neurons in the cat: Evidence for involvement in certain types of ventilatory disturbances. Am J Physiol Regul Integr Comp Physiol. 2003;285:R1287–304

101. Brown KA, Laferrière A, Moss IR. Recurrent hypoxemia in young children with obstructive sleep apnea is associated with reduced opioid requirement for analgesia. ANESTHESIOLOGY. 2004;100:806–10; discussion 5A

102. Brown KA, Laferrière A, Lakheeram I, Moss IR. Recurrent hypoxemia in children is associated with increased analgesic sensitivity to opiates. ANESTHESIOLOGY. 2006;105:665–9

103. Hamilton WK, Cullen SC. Effect of levallorphan tartrate upon opiate induced respiratory depression. ANESTHESIOLOGY. 1953;14:550–4

104. Vaughn RL, Bennett CR. Fentanyl chest wall rigidity syndrome–a case report. Anesth Prog. 1981;28:50–1

105. Drummond GB, Duncan MK. Abdominal pressure during laparoscopy: Effects of fentanyl. Br J Anaesth. 2002;88:384–8

106. Chawla G, Drummond GB. Fentanyl decreases end-expiratory lung volume in patients anaesthetized with sevoflurane. Br J Anaesth. 2008;100:411–4

107. Wu A, Drummond GB. Respiratory muscle activity and respiratory obstruction after abdominal surgery. Br J Anaesth. 2006;96:510–5

108. Aurell J, Elmqvist D. Sleep in the surgical intensive care unit: Continuous polygraphic recording of sleep in nine patients receiving postoperative care. Br Med J (Clin Res Ed). 1985;290:1029–32

109. Kaw R, Michota F, Jaffer A, Ghamande S, Auckley D, Golish J. Unrecognized sleep apnea in the surgical patient: Implications for the perioperative setting. Chest. 2006;129:198–205

110. Borbély AA, Tobler I, Hanagasioglu M. Effect of sleep deprivation on sleep and EEG power spectra in the rat. Behav Brain Res. 1984;14:171–82

111. Knill RL, Moote CA, Skinner MI, Rose EA. Anesthesia with abdominal surgery leads to intense REM sleep during the first postoperative week. ANESTHESIOLOGY. 1990;73:52–61

112. Roth T, Roehrs T. Sleep organization and regulation. Neurology. 2000;54(5 Suppl 1):S2–7

113. Cherniack NS. Respiratory dysrhythmias during sleep. N Engl J Med. 1981;305:325–30

114. Rosenberg J, Wildschiødtz G, Pedersen MH, von Jessen F, Kehlet H. Late postoperative nocturnal episodic hypoxaemia and associated sleep pattern. Br J Anaesth. 1994;72:145–50

115. Ellis BW, Dudley HA. Some aspects of sleep research in surgical stress. J Psychosom Res. 1976;20:303–8

116. Rosenberg-Adamsen S, Skarbye M, Wildschiødtz G, Kehlet H, Rosenberg J. Sleep after laparoscopic cholecystectomy. Br J Anaesth. 1996;77:572–5

117. Pick J, Chen Y, Moore JT, Sun Y, Wyner AJ, Friedman EB, Kelz MB. Rapid eye movement sleep debt accrues in mice exposed to volatile anesthetics. ANESTHESIOLOGY. 2011;115:702–12

118. Moote CA, Knill RL. Isoflurane anesthesia causes a transient alteration in nocturnal sleep. ANESTHESIOLOGY. 1988;69:327–31

119. Eisen J, MacFarlane J, Shapiro CM. ABC of sleep disorders. Psychotropic drugs and sleep. BMJ. 1993;306:1331–4

120. Tung A, Lynch JP, Mendelson WB. Prolonged sedation with propofol in the rat does not result in sleep deprivation. Anesth Analg. 2001;92:1232–6

121. Tung A, Bergmann BM, Herrera S, Cao D, Mendelson WB. Recovery from sleep deprivation occurs during propofol anesthesia. ANESTHESIOLOGY. 2004;100:1419–26

122. Cammu G, De Witte J, De Veylder J, Byttebier G, Vandeput D, Foubert L, Vandenbroucke G, Deloof T. Postoperative residual paralysis in outpatients versus inpatients. Anesth Analg. 2006;102:426–9

123. Eikermann M, Vogt FM, Herbstreit F, Vahid-Dastgerdi M, Zenge MO, Ochterbeck C, de Greiff A, Peters J. The predisposition to inspiratory upper airway collapse during partial neuromuscular blockade. Am J Respir Crit Care Med. 2007;175:9–15

124. Herbstreit F, Peters J, Eikermann M. Impaired upper airway integrity by residual neuromuscular blockade: Increased airway collapsibility and blunted genioglossus muscle activity in response to negative pharyngeal pressure. ANESTHESIOLOGY. 2009;110:1253–60

125. Murphy GS, Szokol JW, Marymont JH, Greenberg SB, Avram MJ, Vender JS, Nisman M. Intraoperative acceleromyographic monitoring reduces the risk of residual neuromuscular blockade and adverse respiratory events in the postanesthesia care unit. ANESTHESIOLOGY. 2008;109:389–98

126. Butterly A, Bittner EA, George E, Sandberg WS, Eikermann M, Schmidt U. Postoperative residual curarization from intermediate-acting neuromuscular blocking agents delays recovery room discharge. Br J Anaesth. 2010;105:304–9

127. Eikermann M, Fassbender P, Malhotra A, Takahashi M, Kubo S, Jordan AS, Gautam S, White DP, Chamberlin NL. Unwarranted administration of acetylcholinesterase inhibitors can impair genioglossus and diaphragm muscle function. ANESTHESIOLOGY. 2007;107:621–9

128. Nguyen-Huu T, Molgó J, Servent D, Duvaldestin P. Resistance to D-tubocurarine of the rat diaphragm as compared to a limb muscle: Influence of quantal transmitter release and nicotinic acetylcholine receptors. ANESTHESIOLOGY. 2009;110:1011–5

129. Trudo FJ, Gefter WB, Welch KC, Gupta KB, Maislin G, Schwab RJ. State-related changes in upper airway caliber and surrounding soft-tissue structures in normal subjects. Am J Respir Crit Care Med. 1998;158:1259–70

130. Herbstreit F, Zigrahn D, Ochterbeck C, Peters J, Eikermann M. Neostigmine/glycopyrrolate administered after recovery from neuromuscular block increases upper airway collapsibility by decreasing genioglossus muscle activity in response to negative pharyngeal pressure. ANESTHESIOLOGY. 2010;113:1280–8

131. Krodel DJ, Bittner EA, Abdulnour RE, Brown RH, Eikermann M. Negative pressure pulmonary edema following bronchospasm. Chest. 2011;140:1351–4

132. Ayala A, Wang P, Ba ZF, Perrin MM, Ertel W, Chaudry IH. Differential alterations in plasma IL-6 and TNF levels after trauma and hemorrhage. Am J Physiol. 1991;260:R167–71

133. Pullicino EA, Carli F, Poole S, Rafferty B, Malik ST, Elia M. The relationship between the circulating concentrations of interleukin 6 (IL-6), tumor necrosis factor (TNF) and the acute phase response to elective surgery and accidental injury. Lymphokine Res. 1990;9:231–8

134. Plank LD, Connolly AB, Hill GL. Sequential changes in the metabolic response in severely septic patients during the first 23 days after the onset of peritonitis. Ann Surg. 1998;228:146–58

135. Leon A, Boczkowski J, Dureuil B, Desmonts JM, Aubier M. Effects of endotoxic shock on diaphragmatic function in mechanically ventilated rats. J Appl Physiol. 1992;72:1466–72

136. Burke JF, Pontoppidan H, Welch CE. High output respiratory failure: an important cause of death ascribed to peritonitis or ileus. Ann Surg. 1963;158:581–95

137. Jammes Y, Balzamo E. Changes in afferent and efferent phrenic activities with electrically induced diaphragmatic fatigue. J Appl Physiol. 1992;73:894–902

138. Reid MB, Lännergren J, Westerblad H. Respiratory and limb muscle weakness induced by tumor necrosis factor-alpha: Involvement of muscle myofilaments. Am J Respir Crit Care Med. 2002;166:479–84

139. Spooner CE, Markowitz NP, Saravolatz LD. The role of tumor necrosis factor in sepsis. Clin Immunol Immunopathol. 1992;62:S11–7

140. Boczkowski J, Lanone S, Ungureanu-Longrois D, Danialou G, Fournier T, Aubier M. Induction of diaphragmatic nitric oxide synthase after endotoxin administration in rats: Role on diaphragmatic contractile dysfunction. J Clin Invest. 1996;98:1550–9

141. Lanone S, Mebazaa A, Heymes C, Henin D, Poderoso JJ, Panis Y, Zedda C, Billiar T, Payen D, Aubier M, Boczkowski J. Muscular contractile failure in septic patients: Role of the inducible nitric oxide synthase pathway. Am J Respir Crit Care Med. 2000;162:2308–15

142. Esteban A, Frutos F, Tobin MJ, Alía I, Solsona JF, Valverdú I, Fernández R, de la Cal MA, Benito S, Tomás R. A comparison of four methods of weaning patients from mechanical ventilation. Spanish Lung Failure Collaborative Group. N Engl J Med. 1995;332:345–50

143. Dasta JF, McLaughlin TP, Mody SH, Piech CT. Daily cost of an intensive care unit day: The contribution of mechanical ventilation. Crit Care Med. 2005;33:1266–71

144. Zakynthinos SG, Vassilakopoulos T, Roussos C. The load of inspiratory muscles in patients needing mechanical ventilation. Am J Respir Crit Care Med. 1995;152:1248–55

145. Vassilakopoulos T, Zakynthinos S, Roussos C. The tension-time index and the frequency/tidal volume ratio are the major pathophysiologic determinants of weaning failure and success. Am J Respir Crit Care Med. 1998;158:378–85

146. Shanely RA, Zergeroglu MA, Lennon SL, Sugiura T, Yimlamai T, Enns D, Belcastro A, Powers SK. Mechanical ventilation-induced diaphragmatic atrophy is associated with oxidative injury and increased proteolytic activity. Am J Respir Crit Care Med. 2002;166:1369–74

147. Levine S, Nguyen T, Taylor N, Friscia ME, Budak MT, Rothenberg P, Zhu J, Sachdeva R, Sonnad S, Kaiser LR, Rubinstein NA, Powers SK, Shrager JB. Rapid disuse atrophy of diaphragm fibers in mechanically ventilated humans. N Engl J Med. 2008;358:1327–35

148. Jaber S, Petrof BJ, Jung B, Chanques G, Berthet JP, Rabuel C, Bouyabrine H, Courouble P, Koechlin-Ramonatxo C, Sebbane M, Similowski T, Scheuermann V, Mebazaa A, Capdevila X, Mornet D, Mercier J, Lacampagne A, Philips A, Matecki S. Rapidly progressive diaphragmatic weakness and injury during mechanical ventilation in humans. Am J Respir Crit Care Med. 2011;183:364–71

149. Mrozek S, Jung B, Petrof BJ, Pauly M, Roberge S, Lacampagne A, Cassan C, Thireau J, Molinari N, Futier E, Scheuermann V, Constantin JM, Matecki S, Jaber S. Rapid onset of specific diaphragm weakness in a healthy murine model of ventilator-induced diaphragmatic dysfunction. ANESTHESIOLOGY. 2012;117:560–7

150. Grosu HB, Lee YI, Lee J, Eden E, Eikermann M, Rose K. Diaphragm muscle thinning in mechanically ventilated patients. Chest. 2012;142:1455–60

151. Behbehani NA, Al-Mane F, D’yachkova Y, Paré P, FitzGerald JM. Myopathy following mechanical ventilation for acute severe asthma: The role of muscle relaxants and corticosteroids. Chest. 1999;115:1627–31

152. Adnet F, Dhissi G, Borron SW, Galinski M, Rayeh F, Cupa M, Pourriat JL, Lapostolle F. Complication profiles of adult asthmatics requiring paralysis during mechanical ventilation. Intensive Care Med. 2001;27:1729–36

153. Leatherman JW, Fluegel WL, David WS, Davies SF, Iber C. Muscle weakness in mechanically ventilated patients with severe asthma. Am J Respir Crit Care Med. 1996;153:1686–90

154. Douglass JA, Tuxen DV, Horne M, Scheinkestel CD, Weinmann M, Czarny D, Bowes G. Myopathy in severe asthma. Am Rev Respir Dis. 1992;146:517–9

155. Garnacho-Montero J, Amaya-Villar R, García-Garmendía JL, Madrazo-Osuna J, Ortiz-Leyba C. Effect of critical illness polyneuropathy on the withdrawal from mechanical ventilation and the length of stay in septic patients. Crit Care Med. 2005;33:349–54

156. Segredo V, Caldwell JE, Matthay MA, Sharma ML, Gruenke LD, Miller RD. Persistent paralysis in critically ill patients after long-term administration of vecuronium. N Engl J Med. 1992;327:524–8

157. Testelmans D, Maes K, Wouters P, Gosselin N, Deruisseau K, Powers S, Sciot R, Decramer M, Gayan-Ramirez G. Rocuronium exacerbates mechanical ventilation-induced diaphragm dysfunction in rats. Crit Care Med. 2006;34:3018–23

158. Scheidegger D, Bentz L, Piolino G, Pusterla C, Gigon JP. Influence of early mobilisation of pulmonary function in surgical patients. Eur J Intensive Care Med. 1976;2:35–40

159. Schweickert WD, Pohlman MC, Pohlman AS, Nigos C, Pawlik AJ, Esbrook CL, Spears L, Miller M, Franczyk M, Deprizio D, Schmidt GA, Bowman A, Barr R, McCallister KE, Hall JB, Kress JP. Early physical and occupational therapy in mechanically ventilated, critically ill patients: A randomised controlled trial. Lancet. 2009;373:1874–82

160. Morris PE, Goad A, Thompson C, Taylor K, Harry B, Passmore L, Ross A, Anderson L, Baker S, Sanchez M, Penley L, Howard A, Dixon L, Leach S, Small R, Hite RD, Haponik E. Early intensive care unit mobility therapy in the treatment of acute respiratory failure. Crit Care Med. 2008;36:2238–43

161. Nava S. Rehabilitation of patients admitted to a respiratory intensive care unit. Arch Phys Med Rehabil. 1998;79:849–54

162. Kasotakis G, Schmidt U, Perry D, Grosse-Sundrup M, Benjamin J, Ryan C, Tully S, Hirschberg R, Waak K, Velmahos G, Bittner EA, Zafonte R, Cobb JP, Eikermann M. The surgical intensive care unit optimal mobility score predicts mortality and length of stay. Crit Care Med. 2012;40:1122–8

163. Qaseem A, Snow V, Fitterman N, Hornbake ER, Lawrence VA, Smetana GW, Weiss K, Owens DK, Aronson M, Barry P, Casey DE Jr, Cross JT Jr, Fitterman N, Sherif KD, Weiss KBClinical Efficacy Assessment Subcommittee of the American College of Physicians. . Risk assessment for and strategies to reduce perioperative pulmonary complications for patients undergoing noncardiothoracic surgery: A guideline from the American College of Physicians. Ann Intern Med. 2006;144:575–80

164. Turner JM, Mead J, Wohl ME. Elasticity of human lungs in relation to age. J Appl Physiol. 1968;25:664–71

165. Sprung J, Gajic O, Warner DO. Review article: Age related alterations in respiratory function - anesthetic considerations. Can J Anaesth. 2006;53:1244–57

166. Tolep K, Higgins N, Muza S, Criner G, Kelsen SG. Comparison of diaphragm strength between healthy adult elderly and young men. Am J Respir Crit Care Med. 1995;152:677–82

167. Eikermann M, Jordan AS, Chamberlin NL, Gautam S, Wellman A, Lo YL, White DP, Malhotra A. The influence of aging on pharyngeal collapsibility during sleep. Chest. 2007;131:1702–9

168. Turnheim K. When drug therapy gets old: Pharmacokinetics and pharmacodynamics in the elderly. Exp Gerontol. 2003;38:843–53

169. Kronenberg RS, Drage CW. Attenuation of the ventilatory and heart rate responses to hypoxia and hypercapnia with aging in normal men. J Clin Invest. 1973;52:1812–9

170. Ogden CL, Carroll MD, Kit BK, Flegal KM. Prevalence of obesity in the United States, 2009–2010. NCHS Data Brief. 2012:1–8

171. Isono S. Obstructive sleep apnea of obese adults: Pathophysiology and perioperative airway management. ANESTHESIOLOGY. 2009;110:908–21

172. Welch KC, Foster GD, Ritter CT, Wadden TA, Arens R, Maislin G, Schwab RJ. A novel volumetric magnetic resonance imaging paradigm to study upper airway anatomy. Sleep. 2002;25:532–42

173. Isono S, Remmers JE, Tanaka A, Sho Y, Sato J, Nishino T. Anatomy of pharynx in patients with obstructive sleep apnea and in normal subjects. J Appl Physiol. 1997;82:1319–26

174. Ladosky W, Botelho MA, Albuquerque JP Jr. Chest mechanics in morbidly obese non-hypoventilated patients. Respir Med. 2001;95:281–6

175. Kress JP, Pohlman AS, Alverdy J, Hall JB. The impact of morbid obesity on oxygen cost of breathing (VO(2RESP)) at rest. Am J Respir Crit Care Med. 1999;160:883–6

176. Shinohara E, Kihara S, Yamashita S, Yamane M, Nishida M, Arai T, Kotani K, Nakamura T, Takemura K, Matsuzawa Y. Visceral fat accumulation as an important risk factor for obstructive sleep apnoea syndrome in obese subjects. J Intern Med. 1997;241:11–8

177. Punjabi NM. The epidemiology of adult obstructive sleep apnea. Proc Am Thorac Soc. 2008;5:136–43

178. Ayuse T, Hoshino Y, Kurata S, Ayuse T, Schneider H, Kirkness JP, Patil SP, Schwartz AR, Oi K. The effect of gender on compensatory neuromuscular response to upper airway obstruction in normal subjects under midazolam general anesthesia. Anesth Analg. 2009;109:1209–18

179. Mezzanotte WS, Tangel DJ, White DP. Waking genioglossal electromyogram in sleep apnea patients versus normal controls (a neuromuscular compensatory mechanism). J Clin Invest. 1992;89:1571–9

180. Horner RL, Innes JA, Morrell MJ, Shea SA, Guz A. The effect of sleep on reflex genioglossus muscle activation by stimuli of negative airway pressure in humans. J Physiol (Lond). 1994;476:141–51

181. Wheatley JR, Tangel DJ, Mezzanotte WS, White DP. Influence of sleep on response to negative airway pressure of tensor palatini muscle and retropalatal airway. J Appl Physiol. 1993;75:2117–24

182. Park JG, Ramar K, Olson EJ. Updates on definition, consequences, and management of obstructive sleep apnea. Mayo Clin Proc. 2011;86:549–54; quiz 554–5

183. Rennotte MT, Baele P, Aubert G, Rodenstein DO. Nasal continuous positive airway pressure in the perioperative management of patients with obstructive sleep apnea submitted to surgery. Chest. 1995;107:367–74

184. Joshi GP, Ankichetty SP, Gan TJ, Chung F. Society for Ambulatory Anesthesia consensus statement on preoperative selection of adult patients with obstructive sleep apnea scheduled for ambulatory surgery. Anesth Analg. 2012;115:1060–8

185. Gross JB, Bachenberg KL, Benumof JL, Caplan RA, Connis RT, Coté CJ, Nickinovich DG, Prachand V, Ward DS, Weaver EM, Ydens L, Yu SAmerican Society of Anesthesiologists Task Force on Perioperative Management. . Practice guidelines for the perioperative management of patients with obstructive sleep apnea: A report by the American Society of Anesthesiologists Task Force on Perioperative Management of patients with obstructive sleep apnea. ANESTHESIOLOGY. 2006;104:1081–93; quiz 1117–8

186. Schiller JS, Lucas JW, Ward BW, Peregoy JA. Summary health statistics for U.S. adults: National Health Interview Survey, 2010. Vital Health Stat. 2012;10:1–207

187. Cassart M, Pettiaux N, Gevenois PA, Paiva M, Estenne M. Effect of chronic hyperinflation on diaphragm length and surface area. Am J Respir Crit Care Med. 1997;156:504–8

188. McKenzie DK, Gorman RB, Tolman J, Pride NB, Gandevia SC. Estimation of diaphragm length in patients with severe chronic obstructive pulmonary disease. Respir Physiol. 2000;123:225–34

189. Zocchi L, Garzaniti N, Newman S, Macklem PT. Effect of hyperinflation and equalization of abdominal pressure on diaphragmatic action. J Appl Physiol. 1987;62:1655–64

190. Brancatisano A, Engel LA, Loring SH. Lung volume and effectiveness of inspiratory muscles. J Appl Physiol. 1993;74:688–94

191. Sheer AJ, Heckman JE, Schneider EB, Wu AW, Segal JB, Feinberg R, Lidor AO. Congestive heart failure and chronic obstructive pulmonary disease predict poor surgical outcomes in older adults undergoing elective diverticulitis surgery. Dis Colon Rectum. 2011;54:1430–7

192. Hawn MT, Houston TK, Campagna EJ, Graham LA, Singh J, Bishop M, Henderson WG. The attributable risk of smoking on surgical complications. Ann Surg. 2011;254:914–20

193. Wilkes AR, Hall JE, Wright E, Grundler S. The effect of humidification and smoking habit on the incidence of adverse airway events during deepening of anaesthesia with desflurane. Anaesthesia. 2000;55:685–9

194. Konrad FX, Schreiber T, Brecht-Kraus D, Georgieff M. Bronchial mucus transport in chronic smokers and nonsmokers during general anesthesia. J Clin Anesth. 1993;5:375–80

195. Kotani N, Hashimoto H, Sessler DI, Yoshida H, Kimura N, Okawa H, Muraoka M, Matsuki A. Smoking decreases alveolar macrophage function during anesthesia and surgery. ANESTHESIOLOGY. 2000;92:1268–77

196. Maestrelli P, Saetta M, Mapp CE, Fabbri LM. Remodeling in response to infection and injury. Airway inflammation and hypersecretion of mucus in smoking subjects with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2001;164:S76–80

197. Squadrone V, Coha M, Cerutti E, Schellino MM, Biolino P, Occella P, Belloni G, Vilianis G, Fiore G, Cavallo F, Ranieri VMPiedmont Intensive Care Units Network (PICUN). . Continuous positive airway pressure for treatment of postoperative hypoxemia: A randomized controlled trial. JAMA. 2005;293:589–95

198. Ramachandran SK, Nafiu OO, Ghaferi A, Tremper KK, Shanks A, Kheterpal S. Independent predictors and outcomes of unanticipated early postoperative tracheal intubation after nonemergent, noncardiac surgery. ANESTHESIOLOGY. 2011;115:44–53

199. Ohtani H, Tamamori Y, Noguchi K, Azuma T, Fujimoto S, Oba H, Aoki T, Minami M, Hirakawa K. Meta-analysis of laparoscopy-assisted and open distal gastrectomy for gastric cancer. J Surg Res. 2011;171:479–85

200. Wisner DH. A stepwise logistic regression analysis of factors affecting morbidity and mortality after thoracic trauma: Effect of epidural analgesia. J Trauma. 1990;30:799–804; discussion 804–5

201. Wu CL, Cohen SR, Richman JM, Rowlingson AJ, Courpas GE, Cheung K, Lin EE, Liu SS. Efficacy of postoperative patient-controlled and continuous infusion epidural analgesia versus intravenous patient-controlled analgesia with opioids: A meta-analysis. ANESTHESIOLOGY. 2005;103:1079–88; quiz 1109–10

202. Pansard JL, Mankikian B, Bertrand M, Kieffer E, Clergue F, Viars P. Effects of thoracic extradural block on diaphragmatic electrical activity and contractility after upper abdominal surgery. ANESTHESIOLOGY. 1993;78:63–71

203. Warner DO, Warner MA, Ritman EL. Human chest wall function during epidural anesthesia. ANESTHESIOLOGY. 1996;85:761–73

204. Ballantyne JC, Carr DB, deFerranti S, Suarez T, Lau J, Chalmers TC, Angelillo IF, Mosteller F. The comparative effects of postoperative analgesic therapies on pulmonary outcome: Cumulative meta-analyses of randomized, controlled trials. Anesth Analg. 1998;86:598–612

205. Bhatnagar A, Mayberry J, Nirula R. Rib fracture fixation for flail chest: What is the benefit? J Am Coll Surg. 2012;215:201–5

206. Ranieri VM, Brienza N, Santostasi S, Puntillo F, Mascia L, Vitale N, Giuliani R, Memeo V, Bruno F, Fiore T, Brienza A, Slutsky AS. Impairment of lung and chest wall mechanics in patients with acute respiratory distress syndrome: Role of abdominal distension. Am J Respir Crit Care Med. 1997;156:1082–91

207. Cheatham ML, Malbrain ML, Kirkpatrick A, Sugrue M, Parr M, De Waele J, Balogh Z, Leppäniemi A, Olvera C, Ivatury R, D’Amours S, Wendon J, Hillman K, Wilmer A. Results from the International Conference of Experts on Intra-abdominal Hypertension and Abdominal Compartment Syndrome. II. Recommendations. Intensive Care Med. 2007;33:951–62

208. Lightowler JV, Wedzicha JA, Elliott MW, Ram FS. Non-invasive positive pressure ventilation to treat respiratory failure resulting from exacerbations of chronic obstructive pulmonary disease: Cochrane systematic review and meta-analysis. BMJ. 2003;326:185

209. Woods BD, Sladen RN. Perioperative considerations for the patient with asthma and bronchospasm. Br J Anaesth. 2009;103:i57–65

210. Kumar A, Roberts D, Wood KE, Light B, Parrillo JE, Sharma S, Suppes R, Feinstein D, Zanotti S, Taiberg L, Gurka D, Kumar A, Cheang M. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med. 2006;34:1589–96

211. . Practice guidelines for acute pain management in the perioperative setting: An updated report by the American Society of Anesthesiologists Task Force on Acute Pain Management. ANESTHESIOLOGY. 2004;100:1573–81

212. Ahmad S, Nagle A, McCarthy RJ, Fitzgerald PC, Sullivan JT, Prystowsky J. Postoperative hypoxemia in morbidly obese patients with and without obstructive sleep apnea undergoing laparoscopic bariatric surgery. Anesth Analg. 2008;107:138–43

213. Jaber S, Delay JM, Chanques G, Sebbane M, Jacquet E, Souche B, Perrigault PF, Eledjam JJ. Outcomes of patients with acute respiratory failure after abdominal surgery treated with noninvasive positive pressure ventilation. Chest. 2005;128:2688–95

214. Marini JJ. Unproven clinical evidence in mechanical ventilation. Curr Opin Crit Care. 2012;18:1–7

215. Chiumello D, Carlesso E, Cadringher P, Caironi P, Valenza F, Polli F, Tallarini F, Cozzi P, Cressoni M, Colombo A, Marini JJ, Gattinoni L. Lung stress and strain during mechanical ventilation for acute respiratory distress syndrome. Am J Respir Crit Care Med. 2008;178:346–55

216. Papazian L, Forel JM, Gacouin A, Penot-Ragon C, Perrin G, Loundou A, Jaber S, Arnal JM, Perez D, Seghboyan JM, Constantin JM, Courant P, Lefrant JY, Guérin C, Prat G, Morange S, Roch AACURASYS Study Investigators. . Neuromuscular blockers in early acute respiratory distress syndrome. N Engl J Med. 2010;363:1107–16

217. Yoshida T, Uchiyama A, Matsuura N, Mashimo T, Fujino Y. Spontaneous breathing during lung-protective ventilation in an experimental acute lung injury model: High transpulmonary pressure associated with strong spontaneous breathing effort may worsen lung injury. Crit Care Med. 2012;40:1578–85

218. Murray MJ, Cowen J, DeBlock H, Erstad B, Gray AW Jr, Tescher AN, McGee WT, Prielipp RC, Susla G, Jacobi J, Nasraway SA Jr, Lumb PDTask Force of the American College of Critical Care Medicine (ACCM) of the Society of Critical Care Medicine (SCCM), American Society of Health-System Pharmacists, American College of Chest Physicians. . Clinical practice guidelines for sustained neuromuscular blockade in the adult critically ill patient. Crit Care Med. 2002;30:142–56

219. Sassoon CS, Zhu E, Caiozzo VJ. Assist-control mechanical ventilation attenuates ventilator-induced diaphragmatic dysfunction. Am J Respir Crit Care Med. 2004;170:626–32

220. Gayan-Ramirez G, Testelmans D, Maes K, Rácz GZ, Cadot P, Zádor E, Wuytack F, Decramer M. Intermittent spontaneous breathing protects the rat diaphragm from mechanical ventilation effects. Crit Care Med. 2005;33:2804–9

221. Hudson MB, Smuder AJ, Nelson WB, Bruells CS, Levine S, Powers SK. Both high level pressure support ventilation and controlled mechanical ventilation induce diaphragm dysfunction and atrophy. Crit Care Med. 2012;40:1254–60

222. Wrigge H, Zinserling J, Neumann P, Muders T, Magnusson A, Putensen C, Hedenstierna G. Spontaneous breathing with airway pressure release ventilation favors ventilation in dependent lung regions and counters cyclic alveolar collapse in oleic-acid-induced lung injury: A randomized controlled computed tomography trial. Crit Care. 2005;9:R780–9

223. Putensen C, Mutz NJ, Putensen-Himmer G, Zinserling J. Spontaneous breathing during ventilatory support improves ventilation-perfusion distributions in patients with acute respiratory distress syndrome. Am J Respir Crit Care Med. 1999;159:1241–8

224. Kress JP, Pohlman AS, O’Connor MF, Hall JB. Daily interruption of sedative infusions in critically ill patients undergoing mechanical ventilation. N Engl J Med. 2000;342:1471–7

225. Liu SS, Wu CL. Effect of postoperative analgesia on major postoperative complications: A systematic update of the evidence. Anesth Analg. 2007;104:689–702

226. Hellström A, Willman A. Promoting sleep by nursing interventions in health care settings: A systematic review. Worldviews Evid Based Nurs. 2011;8:128–42

227. Leray V, Bourdin G, Flandreau G, Bayle F, Wallet F, Richard JC, Guérin C. A case of pneumomediastinum in a patient with acute respiratory distress syndrome on pressure support ventilation. Respir Care. 2010;55:770–3

228. Lagneau F, D’honneur G, Plaud B, Mantz J, Gillart T, Duvaldestin P, Marty J, Clyti N, Pourriat JL. A comparison of two depths of prolonged neuromuscular blockade induced by cisatracurium in mechanically ventilated critically ill patients. Intensive Care Med. 2002;28:1735–41

Cited By:

This article has been cited 1 time(s).

Anesthesiology
Postoperative Respiratory Muscle Dysfunction: Only the Strong Survive
Gropper, MA
Anesthesiology, 118(4): 783-784.
10.1097/ALN.0b013e318288823b
PDF (212) | CrossRef
Back to Top | Article Outline

© 2013 American Society of Anesthesiologists, Inc.

Publication of an advertisement in Anesthesiology Online does not constitute endorsement by the American Society of Anesthesiologists, Inc. or Lippincott Williams & Wilkins, Inc. of the product or service being advertised.
Login

Article Tools

Images

Share